About
Viramal is a UK-based pharmaceutical company developing prescription and non-prescription therapies targeting women's sexual and reproductive health conditions, such as endometriosis, menopause, and chronic pelvic pain, using non-invasive transdermal, buccal, and vaginal drug delivery methods.
Explore Viramal's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.